The Relation between Serum Level of Hs-CRP (High Sensitivity C-Reactive Protein) with the Result of Coronary Vessels Angiography in the Patients with Positive Exercise Treadmill Testing

Document Type : Original Article

Authors

1 Doctor of Medicine, Official Member of Young Researcher Club Young Researchers Club, Kazeroun Branch, Islamic Azad University, Kazeroun, Iran.

2 Assistant Professor of Cardiology. Department of Cardiology, Kazeroun Branch, Islamic Azad University, Kazeroun, Iran.

Abstract

Background and Objective:Experimental and clinical evidence have established inflammatory processes as important contributors to atherosclerosis as well as to the vulnerability of an atherosclerotic lesion to rupture. The purpose of this study was to assess the relationship between plasma level of   hs-CRP as noninvasive evidence of inflammation and its screening efficacy in diagnosis of atherosclerosis and extent of coronary vessels stenosis.
Subjects and Methods: Our 87 cases selected from all patients who came with chief complaint of chest pain and had positive exercise treadmill test in paraclinic examination, and were referred for coronary angiography.  Serum hs-CRP level of all these patient was cheked. Patients with cardiac dysfunction, rheumatic disease and infective disease were excluded from our study. The Patients were divided into two groups according to angiography results: group 1 comprised of   47 patients (24 men vs 23 women) with normal coronary angiography and group 2 comprised of 40 patients (28 men vs 12) with abnormal coronary angiography. The statistical analysis was performed with SPSS version 15.
Results: there was statistically a significant difference between age, sex and positive history of diabetic mellitus between two groups (p< 0.05). Hs-CRP level was similar in both groups. There was no statistically significant correlation between Hs-CRP level and coronary angiography results.
Conclusion: In this study, we found that there is not a clear relationship between plasma level of high sensitivity CRP with exercise induced ischemia, and also extent or the presence of coronary atherosclerosis.

Keywords

References

1-Wilhelmsen L, Wedel H, Tibblin G.. Multivariate analysis of risk factors for coronary heart disease. Ciculation 1973;48(5):950-8.
2-Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350(14):1387–97.
3-Zebrack JS, Muhlestein JB, Horne BD, Anderson JL. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol. 2002;39(4):632-7.
4-Burke AP, Tracy RP, Kolodgie F, Malcom GT, Zieske A, Kutys R, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002;105(17):2019-23.
5-Kervinen H, Palosuo T, Manninen V, Tenkanen L, Vaarala O, Manttari M. Joint effects of C-reactive protein and other risk factors on acute coronary events. Am Heart J 2001;141(4):580-5.
6-Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107(3):391-7.
7-Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004;110(4):380-5.
8-Wilson PW, Pencina M, Jacques P, Selhub J, D'Agostino R Sr, O'Donnell CJ. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes 2008;1(2):92-7.
9-Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107(3):363-9.
10-Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47(3):418-25.
11- Bonow RO, Mann DL, Zipes DP, Lippy P. Braunwald's heart disease : a textbook of cardiovascular medicine . 9th ed. Philadelphia : Saunders Elsevier Press; 2012: Parts I,III,VII
12-Geluk CA, Post WJ, Hillege HL, Tio RA, Tijssen JGP, van Dijk RB, et al. C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort. Atherosclerosis 2008;196(1):372-82.
13-Arroyo-Espliguero R, Avanzas P, Cosin-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004;25(5):401-8.
14-Zairis MN, Papadaki OA, Manousakis SJ, Thoma MA, Beldekos DJ, Olympios CD, et al. C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. Atherosclerosis 2002;164(2):355-9.
15-Miller M, Zhan M, Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Int Med 2005;165(18):2063-8.
16-Shehadeh J, Lewis BS, Weisz G, David M, Ashkenazi T, Halon DA. Relation between C-reactive protein, treadmill exercise testing, and inducible myocardial ischemia. Am J Cardiol 2004;93(5):614-7.
17-Veselka J, Prochazkova S, Duchonova R, Bolomova I, Urbanova Ta, Tesar D, et al. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 2002;13(3):151-4.
18-Shah T, Newcombe P, Smeeth L, Addo J, Casas JP, Whittaker J, et al. Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction. Circ Cardiovasc Genet 2010;3(5):436-44.
19-Mackenzie I, Woodhouse J. C-reactive protein concentrations during bacteraemia: A comparison between patients with and without liver dysfunction. Intensive Care Med 2006;32(9):1344-51.
Jundishapur Scientific Medical Journal
Volume 11, Issue 5
July and August 2017
Pages 499-506

Files

History

  • Receive Date: 03 July 2011
  • Revise Date: 15 April 2012
  • Accept Date: 23 April 2012

Share

How to cite

Statistics